Literature DB >> 6652369

The effects of p-chloromercuribenzoate on muscarinic receptors in the cerebral cortex.

N J Birdsall, A S Burgen, E C Hulme, E H Wong.   

Abstract

The action of p-chloromercuribenzoate (PCMB) on the ligand binding properties of the muscarinic receptors in the rat cerebral cortex has been examined. At low concentrations, PCMB produces a selective change in the binding of agonists without any effect on the binding of antagonists. At higher concentrations, the structure-binding profile for binding antagonists is changed. The affinity of agonists is greatly reduced and the heterogeneity of binding eliminated. The effects of both high and low concentrations of PCMB can be reversed by dithiothreitol. Inactivation of receptors proceeds in parallel and is kinetically complex. It can only be partially reversed by dithiothreitol. Evidence is presented connecting the low affinity agonist binding site with the high affinity pirenzepine binding site. The changes produced by PCMB have been interpreted in terms of the modification of receptor conformation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652369      PMCID: PMC2044982          DOI: 10.1111/j.1476-5381.1983.tb11065.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.

Authors:  J Sedlak; R H Lindsay
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

2.  The character of the muscarinic receptors in different regions of the rat brain.

Authors:  N J Birdsall; E C Hulme; A Burgen
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-02-13

3.  Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain.

Authors:  R S Aronstam; L G Abood; W Hoss
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

4.  The binding of antagonists to brain muscarinic receptors.

Authors:  E C Hulme; N J Birdsall; A S Burgen; P Mehta
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

5.  The binding of agonists to brain muscarinic receptors.

Authors:  N J Birdsall; A S Burgen; E C Hulme
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

6.  Differential effect of N-ethyl maleimide on muscarinic agonist binding in rat and bovine brain membranes.

Authors:  S Carson
Journal:  FEBS Lett       Date:  1980-01-01       Impact factor: 4.124

7.  Nature of regional and chemically-induced differences in the binding properties of muscarinic acetylcholine receptors from rat brain.

Authors:  S R Ikeda; R S Aronstam; M E Eldefrawi
Journal:  Neuropharmacology       Date:  1980-06       Impact factor: 5.250

8.  The importance of thiol- and disulfide groups in agonist and antagonist binding to the muscarinic receptor.

Authors:  B Hedlund; T Bartfai
Journal:  Mol Pharmacol       Date:  1979-05       Impact factor: 4.436

9.  Conversion between configurational states of the muscarinic receptor in rat brain.

Authors:  R S Aronstam; W Hoss; L G Abood
Journal:  Eur J Pharmacol       Date:  1977-12-01       Impact factor: 4.432

10.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

View more
  3 in total

1.  The effect of sulphydryl block on the binding of H1-antagonists to the muscarinic receptor.

Authors:  A S Burgen; C J Harbird
Journal:  Br J Pharmacol       Date:  1983-12       Impact factor: 8.739

2.  Nitric oxide modulates muscarinic acetylcholine receptor binding in the cerebral cortex of gerbils.

Authors:  M Gómez-Vargas; M Asanuma; S Nishibayashi-Asanuma; E Iwata; N Ogawa
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

3.  The effect of p-chloromercuribenzoate on structure-binding relationships of muscarinic receptors in the rat cerebral cortex.

Authors:  N J Birdsall; A S Burgen; E C Hulme; E H Wong
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.